Obsessive-Compulsive Disorder Drugs Market by Product and Geography - Forecast and Analysis 2022-2026

The obsessive-compulsive disorder drugs market share is expected to increase by USD 266.78 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.55%.

This obsessive-compulsive disorder drugs market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers obsessive-compulsive disorder drugs market segmentation by product (SSRI, TSA, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). The obsessive-compulsive disorder drugs market report also offers information on several market vendors, including AbbVie Inc., Apotex Inc., Biohaven Pharmaceutical Holding Co. Ltd., Dr. Reddys Laboratories Ltd., Eli Lilly and Co., GlaxoSmithKline Plc, H Lundbeck AS, Jazz Pharmaceuticals Plc, Lannett Co. Inc., Lupin Ltd., Mallinckrodt Plc, Novartis AG, Omeros Corp., Pfizer Inc., Sun Pharmaceutical Industries Ltd., and Viatris Inc. among others.

What will the Obsessive-Compulsive Disorder Drugs Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Obsessive-Compulsive Disorder Drugs Market Size for the Forecast Period and Other Important Statistics

Obsessive-Compulsive Disorder Drugs Market: Key Drivers, Trends, and Challenges

The rising prevalence of ocd is notably driving the obsessive-compulsive disorder drugs market growth, although factors such as the difficulties in diagnosing OCD may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the obsessive-compulsive disorder drugs industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Obsessive-Compulsive Disorder Drugs Market Driver

One of the key factors driving growth in the obsessive-compulsive disorder drugs market is the rising prevalence of OCD. OCD is a chronic and long-lasting mental disorder. The prevalence of OCD is high in high-income countries due to the drastic change in the lifestyle of individuals. For instance, exposure to the motion picture technologies provoke the individuals about the imaginary /images, intrusive thoughts, and urges. OCD is considered as the fourth most common mental disorder in high-income countries. OCD affects men, women, and children. It is most evident in the childhood, adolescence, or early adulthood stages. Such a high prevalence of the disorder is expected to drive the market over the forecast period.

Key Obsessive-Compulsive Disorder Drugs Market Trend

The increased use of off-label therapies is obsessive-compulsive disorder drugs market trend that is expected to have a positive impact in the coming years. The global OCD drugs market has prescription pharmacological therapies, which involve the use of several approved therapies, as well as off-label therapies from multiple drug classes. Even though the OCD drug market is dominated by approved therapies, the heterogeneous nature of both OCD disorder and patients' response to treatment provides an opportunity for off-label therapies, including vortioxetine, duloxetine, esketamine, aripiprazole, duloxetine, vortioxetine, and risperidone. Many OCD treatment guidelines include the use of off-label therapies as second-line therapies due to relapse and refractory to first-line therapies. The use of off-label therapies will likely increase in the OCD drugs market over the forecast period due to the lack of development of new therapies.

Key Obsessive-Compulsive Disorder Drugs Market Challenge

The difficulties in diagnosing OCD will be a major challenge for the obsessive-compulsive disorder drugs market during the forecast period. OCD is relatively a common disorder, though effective treatment is available, however, it is often underdiagnosed and undertreated by the physicians due to the lack of evidential symptoms. The OCD symptoms may vary from individuals because of the non-disclosure mentality of the patients, below listed are some difficulties for physicians to diagnose the OCD. Hiding symptoms: Patients often hide their symptoms and do not seek help due to lack of awareness and inferiority complex of their behavior. The symptoms can be repeated questioning, difficulty in taking decisions or inability to finalize a decision, procrastination, and constantly seeking reassurance. It is difficult to differentiate OCD from other psychiatric disorders, as most of them have similar symptoms, thus this difficulty in diagnosing has become a major challenge in identifying the OCD.

This obsessive-compulsive disorder drugs market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the obsessive-compulsive disorder (OCD) drugs market as a part of the global pharmaceuticals market within the overall healthcare industry. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the obsessive-compulsive disorder drugs market during the forecast period.

Who are the Major Obsessive-Compulsive Disorder Drugs Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

• AbbVie Inc.
• Apotex Inc.
• Biohaven Pharmaceutical Holding Co. Ltd.
• Dr. Reddys Laboratories Ltd.
• Eli Lilly and Co.
• GlaxoSmithKline Plc
• H Lundbeck AS
• Jazz Pharmaceuticals Plc
• Lannett Co. Inc.
• Lupin Ltd.
• Mallinckrodt Plc
• Novartis AG
• Omeros Corp.
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Viatris Inc.

This statistical study of the obsessive-compulsive disorder drugs market encompasses successful business strategies deployed by the key vendors. The obsessive-compulsive disorder drugs market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Product Insights and News

• abbvie.com - The company offers VRAYLAR that is a prescription medicine used in adults for the treatment of obsessive-compulsive disorder.

• abbvie.com - Under the unified segment, the company conducts research and development, manufacturing, commercialization and sale of innovative medicines and therapies to allocate resources and assess business performance on a global basis in order to achieve established long term strategic goals.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The obsessive-compulsive disorder drugs market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Obsessive-Compulsive Disorder Drugs Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the obsessive-compulsive disorder drugs market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Obsessive-Compulsive Disorder Drugs Market?

For more insights on the market share of various regions Request for a FREE sample now!

55% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for obsessive-compulsive disorder drugs in North America. Market growth in this region will be faster than the growth of the market in the European and ROW regions.

The growing incidence of OCD, government initiatives to combat OCD, and the availability of drugs will facilitate the obsessive-compulsive disorder drugs market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In 2020, the outbreak of COVID-19 had a negative impact on the regional market. Due to major focus on treating patient with COVID-19, healthcare facilities for other treatments reduced including mental disorders like OCD. However, due to pandemic incidences,OCD has increased in people mainly in post recovery of infection. COVID-19 triggered prevalence of OCD and anxiety. Such factor sustained the stable demand for OCD drugs amidst the pandemic outbreak in region. Moreover, resuming R and D programs for development of new OCD molecules will boost the sales of OCD drugs market in region during the forecast period.

What are the Revenue-generating Product Segments in the Obsessive-Compulsive Disorder Drugs Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The obsessive-compulsive disorder drugs market share growth by the SSRI segment will be significant during the forecast period. The availability of a large number of SSRIs in the market, such as fluoxetine, fluvoxamine, paroxetine, sertraline, citalopram, and escitalopram drive the growth of the segment. Major countries and some organizations, like the US, the European Union (EU), and Japan, have approved many generic versions due to the high demand for SSRI. Some companies are developing controlled release and sustained release formulations of SSRI. Such new drugs are expected to accelerate the market during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the obsessive-compulsive disorder drugs market size and actionable market insights on post COVID-19 impact on each segment.

Request for a FREE sample

What are the Key Data Covered in this Obsessive-Compulsive Disorder Drugs Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive obsessive-compulsive disorder drugs market growth during the next five years
• Precise estimation of the obsessive-compulsive disorder drugs market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the obsessive-compulsive disorder drugs industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of obsessive-compulsive disorder drugs market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch